Skin Hydration in Persons With Acne After Dietary Supplementation With Botanical Antioxidants (KIWIBOOSTER)

University of California, Los Angeles (UCLA)

Status

Withdrawn

Conditions

Acne

Acne Vulgaris

Treatments

Dietary Supplement: HBKB Capsule

Other: HBKB Supplement Vehicle

Study type

Interventional

Funder types

Other

Identifiers

NCT04534140

19-002095

Details and patient eligibility

About

Antioxidants have been studied for their abilities to combat reactive oxygen species in a multitude of conditions. This study aims to assess whether the botanical dietary supplement 'Halo Beauty Kiwi Booster' (HBKB), taken orally daily for 8 weeks, can assist with Acne vulgaris as well as skin hydration and quality of life for those with acne.

Full description

The study will be a 2-armed investigational trial with one group receiving botanical dietary supplement and one placebo group provided with the similar supplement vehicle. The trial will be double-blind, randomized, parallel-group study. The investigational group will receive the botanical dietary supplement 'Halo Beauty Kiwi Booster' (HBKB), to be taken orally daily for 8 weeks. Control group participants will receive the HBKB botanical dietary supplement vehicle as a placebo to be taken orally daily for 8 weeks.Participants will have their skin assessed

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Adults 18-35 years of age able to provide consent to participate
IGA of mild to moderately severe facial Acne Vulgaris (AV) at screening
Potential participants with mild to moderately severe facial AV and with AV on their neck, shoulders, chest and/or back body surface areas may be included.

Exclusion criteria

An Investigator Global Assessment IGA of severe facial, neck, back or truncal AV
Diagnosis of a chronic inflammatory disease such as lupus, multiple sclerosis, cancer, Chron's disease or cancer
Allergies to Astaxanthin (microalgae), Grape Seed Extract, Kiwi fruit or Kiwi extract, Pineapple fruit or extract (bromelain), Rosehip or Rosehip extract, Gooseberry, Rosehip, Grapes
Secondary AV, such as occupational AV, steroid induced AV, or AV associated with endocrine disorders
Having facial dermatosis that may interfere evaluations by IGA such as sunburn, eczema, psoriasis, erythematotelangectatic rosacea or seborrheic dermatitis
Use of isotretinoin within 2 months
Use of adapalene or tretinoin within 2 weeks
Use of anti-biotics within 2 weeks
Use of oral corticosteroids or androgens within 2 weeks
Use of anticonvulsants
Any subject who the PI deems unsuitable for any reason